Overall, it appears that CDK4/6 inhibition leads to less or equal absolute numbers of CD3+ T cells in the tumor microenvironment (109, 110), suggesting a possible anti-proliferative effect of CDK4/6i on these cells. Here, CDK4 is linked to neoplasm.